Fed Pullback Pledge...
Health Care: Drugs
Dr. Reddy Laboratories Ltd. (RDY: NYSE)
$35.64 -1.07 | -2.91%
06/19/13 - 04:04 PM ET
Portfolios with RDY
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- Contributor6 Best-Performing Emerging ...
- Contributor7 India Stocks With Upside
- ContributorPharma Short Squeezes for 2011
- UserFranks
- Contributor6 Indian Growth Stocks With...
- Contributor5 Drug Stocks With Upside P...
- ContributorTop 10 Emerging Markets Sto...
- UserMy Portfolio
- ContributorTop 10 Emerging Markets Sto...
Latest RDY Headlines from TheStreet
- DVAX, RDY, ONXX, ALXN And VRX, 5 Health Care Stocks Pushing The Sector Lower 06.10.13 | 01:06 pm
- 8 Stocks Surging on Big Volume 04.01.13 | 03:04 pm
- 4 Stocks Raising The Health Care Sector Higher 04.01.13 | 01:04 pm
- 3 Stocks Pushing The Drugs Industry Higher 11.27.12 | 12:11 pm
- Dr. Reddy's Laboratories Management Discusses Q1 2013 Results - Earnings Call Transcript 07.19.12 | 10:07 pm
- Dr. Reddy Stock To Go Ex-dividend Tomorrow (RDY) 06.26.12 | 10:06 am
- Dr. Reddy's Laboratories' CEO Discusses Q4 2012 Results - Earnings Call Transcript 05.11.12 | 05:05 pm
- Dr. Reddy's Laboratories' CEO Discusses Q3 2012 Results - Earnings Call Transcript 02.03.12 | 05:02 pm
- Dr. Reddy's Laboratories' CEO Discusses Q2 2012 Results - Earnings Call Transcript 10.25.11 | 03:10 pm
- 6 Best-Performing Emerging Market ADRs 10.13.11 | 05:10 pm
Press Releases for RDY
- Dr. Reddy’s And Nordion Inc. (formerly MDS Inc.) Settle Claims - Business Wire 03.22.13 | 11:03 am
- Dr. Reddy’s Laboratories Announces Dr. K. Anji Reddy Has Passed Away - Business Wire 03.15.13 | 11:03 am
- Dr. Reddy’s Announces The Launch Of Zoledronic Acid Injection - Business Wire 03.05.13 | 12:03 am
- Dr. Reddy’s Holds 98.6% Of The Shares In OctoPlus After The Post Closing Acceptance Period - Business Wire 02.28.13 | 01:02 am
- Dr. Reddy's Q3 & 9 Months FY13 Financial Results - Business Wire 02.14.13 | 05:02 am
- Dr. Reddy's Declares Offer For OctoPlus Unconditional - Business Wire 02.12.13 | 03:02 am
- Dr. Reddy's To Release Q3 FY13 Results On February 14, 2013 - Business Wire 02.06.13 | 01:02 am
- Dr. Reddy’s Announces The Launch Of Desloratadine ODT (Orally Disintegrating Tablets) - Business Wire 01.25.13 | 12:01 am
- Dr. Reddy’s Announces The Launch Of Finasteride Tablets - Business Wire 01.03.13 | 12:01 am
- Dr. Reddy’s Launches The Recommended Public Cash Offer For All The Issued And Outstanding Ordinary Shares Of OctoPlus N.V. - Business Wire 12.14.12 | 12:12 am
Partner Headlines for RDY
- Favorable Verdict for Mylan - Analyst Blog - Zacks 05.23.13 | 12:05 am
- Another Generic from Dr. Reddy's - Analyst Blog - Zacks 11.23.12 | 09:11 am
- Solid Quarter at Dr. Reddy's - Analyst Blog - Zacks 10.31.12 | 10:10 am
- This Drug Market Could Expand 80-Fold by 2020 - NASDAQ 10.17.12 | 01:10 pm
- Emerging Market Health Care: Prognosis Profitable - Seeking Alpha 10.10.12 | 09:10 am
- Dr. Reddy's Launches Generic Amoxil - Analyst Blog - Zacks 09.21.12 | 05:09 pm
- Merck KGaA Boosts Oncology Pipeline - Analyst Blog - NASDAQ 09.11.12 | 09:09 pm
- Perrigo Cut to Neutral - Analyst Blog - NASDAQ 09.05.12 | 09:09 pm
- Merck KGaA to Acquire Biochrom AG - Analyst Blog - NASDAQ 08.24.12 | 10:08 pm
- Merck KGaA to Acquire Biochrom AG - Analyst Blog - Zacks 08.24.12 | 07:08 pm
